Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of daptomycin for gram-positive infections

F P Tally1, M F DeBruin

  • 1Cubist Pharmaceuticals, Inc., 24 Emily Street, Cambridge, MA 02139, USA. ftally@cubist.com

The Journal of Antimicrobial Chemotherapy
|October 6, 2000
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Daptomycin: a novel agent for Gram-positive infections.

Expert opinion on investigational drugs·2005
Same author

A pilot trial of recombinant interleukin-12 in patients with chronic hepatitis C who previously failed treatment with interferon-alpha.

The American journal of gastroenterology·2001
Same author

Once-daily dosing in dogs optimizes daptomycin safety.

Antimicrobial agents and chemotherapy·2000
Same author

Drug target validation: lethal infection blocked by inducible peptide.

Proceedings of the National Academy of Sciences of the United States of America·2000
Same author

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.

Gastroenterology·1999
Same author

Antimicrobial resistance in anaerobes.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1997